Broad-Spectrum Antibiotic Eye/Ear Drops Franchise in Ahmedabad

Polymyxin B + Chloramphenicol Eye/Ear Drops Supplier in Mumbai

Ophthalmic & Otic Infection Care Distributor in Delhi

Antibiotic Eye/Ear Drops PCD Pharma Franchise in Bangalore

Polyflip C Eye/Ear Drops Stockist in Hyderabad
Ophthalmic & Otic Antibiotic Eye/Ear Drops Manufacturer & Exporter in Chandigarh

Home/Products /polymyxin-b-5000iu-ml-chloramphenicol-4mg-ml-eye-ear-drops-eye-drop

Polyflip C Eye-Ear Drops

Composition : Polymyxin B (5000IU/ml) + Chloramphenicol (4mg/ml) Eye-Ear Drops

Dosage Form : Eye Drops

Packaging Type : Dropper

Packaging : 5ml

Price : ₹0/-

Polyflip C Eye Drops contain Polymyxin B (5000 IU/ml) + Chloramphenicol (4 mg/ml), a broad-spectrum antibiotic combination designed for treating bacterial infections of the eye and ear. This dual-action formulation ensures rapid bacterial eradication and relief from inflammation and discomfort.

Polymyxin B targets Gram-negative bacteria, while Chloramphenicol provides broad Gram-positive coverage, making Polyflip C suitable for conjunctivitis, keratitis, otitis externa, and other ocular and ear bacterial infections.

Clinically, Polyflip C Eye Drops support safe and effective therapy, with optimal dosing that enhances patient adherence and recovery outcomes. Its combined antibiotic action minimizes the risk of persistent infection or recurrence.

From a business perspective, Polyflip C Eye Drops belong to the high-demand ophthalmic and otic antibiotic segment, offering strong prescription flow, repeat sales, and high-margin PCD franchise opportunities. Its clinical trust and broad usage make it a valuable addition for distributors and stockists across India.

Read More

About the Product

Polyflip C Eye Drops contain Polymyxin B (5000 IU/ml) + Chloramphenicol (4 mg/ml), a broad-spectrum antibiotic combination designed for treating bacterial infections of the eye and ear. This dual-action formulation ensures rapid bacterial eradication and relief from inflammation and discomfort.

Polymyxin B targets Gram-negative bacteria, while Chloramphenicol provides broad Gram-positive coverage, making Polyflip C suitable for conjunctivitis, keratitis, otitis externa, and other ocular and ear bacterial infections.

Clinically, Polyflip C Eye Drops support safe and effective therapy, with optimal dosing that enhances patient adherence and recovery outcomes. Its combined antibiotic action minimizes the risk of persistent infection or recurrence.

From a business perspective, Polyflip C Eye Drops belong to the high-demand ophthalmic and otic antibiotic segment, offering strong prescription flow, repeat sales, and high-margin PCD franchise opportunities. Its clinical trust and broad usage make it a valuable addition for distributors and stockists across India.

Common side effects may include mild stinging or burning, temporary blurred vision, eye or ear irritation, or redness. Rarely, hypersensitivity reactions, allergic dermatitis, or secondary infections may occur.

Polyflip C Eye/Ear Drops are indicated for the treatment of bacterial infections of the eye and external ear, such as conjunctivitis, keratitis, and otitis externa caused by susceptible microorganisms. Use should be guided by an ophthalmologist or ENT specialist.

Use Polyflip C Eye/Ear Drops strictly as prescribed by a healthcare professional. Avoid touching the dropper tip to the eye, ear, or any surface to prevent contamination. Complete the full course even if symptoms improve. Discontinue and consult a doctor if severe irritation, allergic reactions, or worsening infection occurs.

Store in a cool, dry place below 25°C. Protect from direct sunlight, keep the bottle tightly closed, and out of reach of children. Do not use beyond the expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation